Riboswitches and Translation Control
Breaker RR. Cold Spring Harb Perspect Biol. 2018 May 29. pii: a032797. PubMed
RNA-Targeted Therapeutics
Crooke ST, Witztum JL, Bennett CF, Baker BF. Cell Metab. 2018 Apr 3;27(4):714-739. PubMed
Aptamer chemistry
Röthlisberger P, Hollenstein M. Adv Drug Deliv Rev. 2018 Apr 4. PubMed
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Urbanski LM, Leclair N, AnczukĂ³w O. Wiley Interdiscip Rev RNA. 2018 Apr 25:e1476. PubMed
Nucleic acids delivering nucleic acids
Catuogno S, Esposito CL, Condorelli G, de Franciscis V. Adv Drug Deliv Rev. 2018 Apr 6. pii: S0169-409X(18)30058-9 PubMed
Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
Miniarikova J, Evers MM, Konstantinova P. Mol Ther. 2018 Apr 4;26(4):947-962. PubMed
Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury
Ong SB, Katwadi K, Kwek XY, Ismail NI, Chinda K, Ong SG, Hausenloy DJ. Expert OpinTher Targets. 2018 Mar;22(3):247-261. PubMed
MetazoanMicroRNAs
Bartel DP. Cell. 2018 Mar 22;173(1):20-51. PubMed
Anti-miRNAoligonucleotides: A comprehensiveguide for design
Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. RNA Biol. 2018 Mar 23:1-15. PubMed
Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them
Leppek K, Das R, Barna M. Nat Rev Mol Cell Biol. 2018 Mar;19(3):158-174. PubMed